I was reading the Readers Digest (may 2013)…as you do, and I saw an article about the work of Prof Alistair Compston and Dr Alisdair Coles. It is expousing the benefits of Alemtumab or Campath. Anyone been on it or have any comments?
It’s not used for PPMS, but probably the best treatment out there for the newly diagnosed RRMS. This is the Barts & London take on it: http://multiple-sclerosis-research.blogspot.co.uk/2013/06/good-news-alemtuzumab-gets-first-line.html